Ultrahuman, a startup tracking sleep and glucose levels, is near a deal to raise over $120 million led by WestBridge Capital, valuing the company at $550-$600 million, a 4.5X increase from March 2024. The funding reflects growing health consciousness and investor interest in longevity science. Ultrahuman's revenue has doubled, reaching a $150 million run rate.
Source: FlipItMoney
Ad
Ad